Track topics on Twitter Track topics that are important to you
Shares of Inflarx NV (IFRX) are up more than 50% year-to-date while the iShares NASDAQ Biotechnology Index (ETF) has gained only 2% during the same period.
InflaRx N.V. (Nasdaq:IFRX), the biopharmaceutical company developing new therapeutics in the terminal complement space, will present at the following conferences: ...
InflaRx GMBH netted $93mm in its initial public offering of 6.67mm common shares at $15 (mid-point of $14-16 filing range). The company had raised four prior rounds of venture funding including its S...
InflaRx hält Vorträge auf zwei wissenschaftlichen Konferenzen im Februar 2018 DGAP-News: InflaRx N.V. / Schlagwort(e): Konferenz InflaRx hält Vorträge auf zwei wissenschaftlichen Konferenzen im Fe...
InflaRx gibt Wahl von Tony Gibney zum Mitglied des Aufsichtsrats bekannt DGAP-News: InflaRx N.V. / Schlagwort(e): Personalie InflaRx gibt Wahl von Tony Gibney zum Mitglied des Aufsichtsrats bekann...
Stock Monitor: bluebird bio Post Earnings Reporting LONDON, UK / ACCESSWIRE / March 12, 2018 / Active-Investors.com has just released a free research report on InflaRx N.V. (NASDAQ: IFRX). If you w...
The FDA has accepted an IND application by biopharmaceutical company, InflaRx, which will enable the company to initiate a Phase IIb study evaluating the efficacy and safety of IFX-1 in patients with ...
Die Listung an der US-Technologiebörse Nasdaq beschert der Thüringer Firma Inflarx etwa 100 Millionen Dollar vom Kapitalmarkt. Das Geld soll in Forschung, Studien und die Zulassung von Wirkstoffen ....
InflaRx (Nasdaq:IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and spec...
InflaRx is a clinical-stage biopharmaceutical company focusing on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibito...
About: Affentranger Associates SA
We have published hundreds of InflaRx N.V. news stories on BioPortfolio along with dozens of InflaRx N.V. Clinical Trials and PubMed Articles about InflaRx N.V. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of InflaRx N.V. Companies in our database. You can also find out about relevant InflaRx N.V. Drugs and Medications on this site too.
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...